Citation only
via Europe PMC
Harnessing cGAS-STING in neurodegeneration: From mitochondrial DNA leakage and microglial reactivity to species-specific translational barriers.
Wang M, Li J, Wang X, Chai X, Luo J, Zhang Y, Chang X, Sun Y, Wang H.
Cytokine & growth factor reviews · 2026
Abstract
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, a cornerstone of innate immunity, has emerged as a critical driver of sterile neuroinflammation in the aging brain. Age-related decline in mitochondrial quality control, coupled with nuclear and lysosomal erosion, fosters the aberrant accumulation of cytosolic self-DNA, establishing a permissive environment for chronic cGAS-STING activation. This review synthesizes recent breakthroughs elucidating how major neurodegenerative diseases-Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease-converge on this pathway through distinct, disease-specific triggers, ranging from PINK1/Parkin deficiency-driven mitochondrial DNA leakage to TDP-43 proteinopathy-associated retrotransposon de-repression. Critically, we evaluate the translational landscape, highlighting the profound challenge posed by species-specific pharmacology, as exemplified by the failure of the covalent inhibitor H-151 to engage human STING. We argue that the future of therapeutic intervention lies not in wholesale pathway ablation, but in nuanced, context-dependent fine-tuning that disentangles its detrimental chronic effects from its indispensable homeostatic functions. This review positions the cGAS-STING axis as a promising yet delicate frontier for combating age-related neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.cytogfr.2026.101537
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
M, W., J, L., X, W., X, C., J, L., Y, Z., X, C., Y, S., & H., W. (2026). Harnessing cGAS-STING in neurodegeneration: From mitochondrial DNA leakage and microglial reactivity to species-specific translational barriers. <em>Cytokine & growth factor reviews</em>. https://doi.org/10.1016/j.cytogfr.2026.101537
Vancouver
M W, J L, X W, X C, J L, Y Z, et al. Harnessing cGAS-STING in neurodegeneration: From mitochondrial DNA leakage and microglial reactivity to species-specific translational barriers. Cytokine & growth factor reviews. 2026. doi:10.1016/j.cytogfr.2026.101537.
BibTeX
@article{wang2026Harnes,
title = {Harnessing cGAS-STING in neurodegeneration: From mitochondrial DNA leakage and microglial reactivity to species-specific translational barriers.},
author = {Wang M and Li J and Wang X and Chai X and Luo J and Zhang Y and Chang X and Sun Y and Wang H.},
journal = {Cytokine & growth factor reviews},
year = {2026},
doi = {10.1016/j.cytogfr.2026.101537},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Neuropharmacology 2024
Preprint · CC-BY
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications
Molecular Neurodegeneration 2010
Open access · CC-BY
Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease
International journal of molecular sciences 2026
Open access · OA
Proteasome Dysfunction and Aggregation-Prone Proteins in Neurodegenerative Diseases: From Mechanisms to Therapeutic Opportunities.
International Journal of Molecular Sciences 2026
Open access · CC-BY
Proteasome Dysfunction and Aggregation-Prone Proteins in Neurodegenerative Diseases: From Mechanisms to Therapeutic Opportunities
The Yale journal of biology and medicine 2026
Open access · OA
Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities.
The Yale Journal of Biology and Medicine 2026
Open access · CC-BY